The Majority of Pediatric Patients respond well to Claritine^TM1

82%

of children treated with Claritine^TM (loratadine) had a good or excellent therapeutic response¹

1. Lutsky BN, Kl.se P, Melon J, et al. A comparative study of the efficacy and safety of loratadine syrup and 1993;15(5):855-65
terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis. Clin Ther.

Claritine^TM is effective across multiple allergic rhinitis symptoms in children¹

Children receiving Claritine^TM had a lower TSS across multiple symptoms when compared with a placebo¹

Adapted from Yang YH et al. 2001 trial involving 46 children (aged 3−12 years) with allergic rhinitis.² Results from a 3-week, double-blind, placebo-controlled, randomised TSS=total symptom score; qd=once daily week (day 15-day 21) symptom scores from the diary cards between the two groups. The efficacy of loratadine syrup for these 4 symptoms was evaluated by comparing the last

1. Yang YH, Lin YT, Lu MY, et al. A double-blind, placebo-controlled, and randomized study of loratadine (ClaritineTM) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol. 2001;19(3):171-55

Claritine^TM is effective across multiple allergic rhinitis symptoms in children¹

Children receiving Claritine^TM (loratadine qd) had 3-week therapeutic period¹ a significantly lower TSS vs placebo during the 3-week therapeutic period¹.


 

Adapted from Yang YH et al. 2001
Results from a 3-week, double-blind, placebo-controlled, randomised trial involving 46 children (aged 3−12 years) with allergic rhinitis.²
TSS=total symptom score; qd=once daily.
The efficacy of loratadine syrup for these 4 symptoms was evaluated by comparing the last week (day 15-day 21) symptom scores from the diary cards between the two groups.

1. Yang YH, Lin YT, Lu MY, et al. A double-blind, placebo-controlled, and randomized study of loratadine (Claritine^TM) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol. 2001;19(3):171-55

With one dose per day that lasts for 24hrs, ClaritineTM is the shield that allows children to treat their allergy monster all day and night.^1,2
 

1. Mendoza de Morales T, S.nchez F. Clinical efficacy and safety of a combined Loratadine betamethasone oral solution in the treatment of severe pediatric perennial allergic rhinitis. World
2. Yang YH, Lin YT, Lu MY, et al. A double-blind, placebo-controlled, and randomized study of loratadine (Claritine^TM) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Allergy Organ J. 2009;2(4):49-53 Asian Pac J Allergy Immunol. 2001;19(3):171-5

ClaritineTM is well tolerated in the treatment of AR in patients as young as 2 years old.¹
 

qd=once-daily
Adapted from Salmun LM et al. 2000.
Results from a 15-day randomised, double-blind placebo controlled study evaluating the safety of Claritine^TM(loratadine 5 mg qd) in 121 paediatric AR patients between 2 and 5 years of age.¹

1. Salmun LM, Herron JM, Banfield C, et al. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther. 2000;22(5):613-21.

Short-term administration of Claritine^TM (loratadine) does not impair children’s performance in school.¹





Adapted from Bender et al. 2001. Results from a parallel-group, double-blind, placebo Controlled study on 63 children between 8 and 10 years of age with allergic rhinitis. short-term administration of diphenhydramine or loratadine. J Pediatr. 2001;138(5):656-60

1. Bender BG, McCormick DR, Milgrom H. Children’s school performance is not impaired by